Treatment Outcome of Children With Multisystem Langerhans Cell Histiocytosis: The Experience of a Single Children’s Hospital in Shanghai, China

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of pediatric hematology/oncology

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPH.0000000000001016PMID 29200145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

  2016cited by this paper
• Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy

  2016cited by this paper
• Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

  2016cited by this paper
• Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.

  2015cited by this paper
• How I treat Langerhans cell histiocytosis.

  2015cited by this paper
• Up‐front therapy for LCH: is it time to test an alternative to vinblastine/prednisone?

  2015cited by this paper
• Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001–2010

  2014cited by this paper
• Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.

  2013cited by this paper
• Improved outcome for children with non‐high risk acute lymphoblastic leukaemia after using an ALL IC‐BFM 2002‐based protocol in Shanghai, China

  2013cited by this paper
• Registration of cancer in girls remains lower than expected in countries with low/middle incomes and low female education rates

  2012cited by this paper
• Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome.

  2012cited by this paper
• Multisystem Langerhans Cell Histiocytosis in Children

  2011cited by this paper
• Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.

  2008cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.

  2001cited by this paper
• Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.

  1994cited by this paper
• Treatment strategy for disseminated langerhans cell histiocytosis

  1994cited by this paper
• Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).

  1989cited by this paper
• Etoposide in recurrent childhood Langerhans' cell histiocytosis: An Italian cooperative study

  1988cited by this paper
• Histiocytosis x--an analysis of prognostic factors.

  1975cited by this paper

• Survival outcomes and adverse prognostic factors of Langerhans cell histiocytosis: a 40-year experience from a single tertiary center in Thailand

  2026cites this paper
• Langerhans cell histiocytosis in an infant

  2024cites this paper
• Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH‐LCH 2014 protocol study

  2023cites this paper
• PET/CT Showing a Case of Langerhans Cell Histiocytosis Involving the Pleura.

  2022cites this paper
• Clinical outcomes and screening for organ involvement in pediatric Langerhans cell histiocytosis in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group

  2022cites this paper
• Childhood Langerhans Cell Histiocytosis (LCH) - A ten year study from Pakistan

  2022cites this paper
• Clinical characteristics and outcomes of Langerhans cell histiocytosis at a single institution in Thailand: a 20-year retrospective study

  2021cites this paper
• Solitary tibial lesion as the initial presentation of Langerhans cell histiocytosis: report of two cases and literature review

  2021cites this paper
• Clinical features and treatment of Langerhans cell histiocytosis

  2021cites this paper
• Langerhans Cell histiocytosis.

  2020cites this paper
• Incidence and radiological pattern of eosinophilic granuloma: a retrospective study in a Chinese tertiary hospital

  2019cites this paper
• A novel fusion gene PLEKHA6‐NTRK3 in langerhans cell histiocytosis

  2018cites this paper
• Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China

  2018cites this paper